Medscape (11/22, Brooks, Subscription Publication) reported, “Longer cumulative use of medication to treat attention-deficit/hyperactivity disorder (AD/HD) is associated with a small, but statistically significant, increased risk for cardiovascular disease (CVD), results of a large Swedish nested case-control study suggest.” Published in JAMA Psychiatry, the study found “the increased risk was evident only for hypertension and arterial disease, was dose-dependent, and was higher for stimulant than nonstimulant AD/HD medications.”
MedPage Today (11/22, DePeau-Wilson) reported researchers “found that through the entire follow-up period, each 1-year increase in use of AD/HD drugs was tied to a 4% increased risk of CVD…and the corresponding increase for the first 3 years was 8%. … They said they saw similar results when looking at children or youth and adults separately.”
Cardiovascular Business (11/22, Walter) also reported.
Related Links:
— “ADHD medications associated with heightened CVD risk,” Michael Walter, Cardiovascular Business, November 22, 2023